国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Borrelia burgdorferi TPR repeat-containing protein BB_0298 (BB_0298) CSB-YP690944BUD
CSB-EP690944BUD
CSB-BP690944BUD
CSB-MP690944BUD
CSB-EP690944BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized protein HI_0976 (HI_0976), partial CSB-YP690945HTA1
CSB-EP690945HTA1
CSB-BP690945HTA1
CSB-MP690945HTA1
CSB-EP690945HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Protein TusC homolog (tusC) CSB-YP690946HTA
CSB-EP690946HTA
CSB-BP690946HTA
CSB-MP690946HTA
CSB-EP690946HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse SPRY domain-containing SOCS box protein 3 (Spsb3) CSB-YP690947MO
CSB-EP690947MO
CSB-BP690947MO
CSB-MP690947MO
CSB-EP690947MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechocystis sp. Uncharacterized protein slr0014 (slr0014), partial CSB-YP690948SSQ1
CSB-EP690948SSQ1
CSB-BP690948SSQ1
CSB-MP690948SSQ1
CSB-EP690948SSQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Protein klaA (klaA) CSB-YP690949ENL
CSB-EP690949ENL
CSB-BP690949ENL
CSB-MP690949ENL
CSB-EP690949ENL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Colicin-E5 immunity protein in ColE9 CSB-YP690950ENL
CSB-EP690950ENL
CSB-BP690950ENL
CSB-MP690950ENL
CSB-EP690950ENL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized membrane protein HI_1307 (HI_1307), partial CSB-YP690951HTA1
CSB-EP690951HTA1
CSB-BP690951HTA1
CSB-MP690951HTA1
CSB-EP690951HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant UDP-glucose 6-dehydrogenase (cap3A) CSB-YP690952FMW
CSB-EP690952FMW
CSB-BP690952FMW
CSB-MP690952FMW
CSB-EP690952FMW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Putative uncharacterized protein HI_1475 (HI_1475), partial CSB-YP690953HTA1
CSB-EP690953HTA1
CSB-BP690953HTA1
CSB-MP690953HTA1
CSB-EP690953HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus filamentous virus 2 Uncharacterized protein ORF208 (ORF208) CSB-YP690954ADAI
CSB-EP690954ADAI
CSB-BP690954ADAI
CSB-MP690954ADAI
CSB-EP690954ADAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus filamentous virus 2 Uncharacterized protein ORF286a (ORF286a) CSB-YP690955ADAI
CSB-EP690955ADAI
CSB-BP690955ADAI
CSB-MP690955ADAI
CSB-EP690955ADAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus filamentous virus 2 Uncharacterized protein ORF413 (ORF413), partial CSB-YP690956ADAI1
CSB-EP690956ADAI1
CSB-BP690956ADAI1
CSB-MP690956ADAI1
CSB-EP690956ADAI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus filamentous virus 2 Uncharacterized protein ORF61 (ORF61), partial CSB-YP690957ADAI
CSB-EP690957ADAI
CSB-BP690957ADAI
CSB-MP690957ADAI
CSB-EP690957ADAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus filamentous virus 2 Uncharacterized protein ORF217b (ORF217b) CSB-YP690958ADAI
CSB-EP690958ADAI
CSB-BP690958ADAI
CSB-MP690958ADAI
CSB-EP690958ADAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidianus filamentous virus 2 Uncharacterized protein ORF181 (ORF181) CSB-YP690959ADAI
CSB-EP690959ADAI
CSB-BP690959ADAI
CSB-MP690959ADAI
CSB-EP690959ADAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechocystis sp. Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD) CSB-YP690960SSQ
CSB-EP690960SSQ
CSB-BP690960SSQ
CSB-MP690960SSQ
CSB-EP690960SSQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized periplasmic iron-binding protein HI_0362 (HI_0362) CSB-YP690961HTA
CSB-EP690961HTA
CSB-BP690961HTA
CSB-MP690961HTA
CSB-EP690961HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Outer membrane protein 26 (omp26) CSB-YP690962HTA
CSB-EP690962HTA
CSB-BP690962HTA
CSB-MP690962HTA
CSB-EP690962HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Borrelia burgdorferi Flagellar motor switch protein FliM (fliM) CSB-YP690963BUD
CSB-EP690963BUD
CSB-BP690963BUD
CSB-MP690963BUD
CSB-EP690963BUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>